About 500 reports

Its signs and symptoms include weight loss, fever, hypertension, malaise, night sweats, and blood in the urine.

  • Oncology
  • Opioid
  • Argos Therapeutics, Inc.
  • AstraZeneca PLC
  • AVEO Oncology

GLOBALDATA EPIDEMIOLOGISTS CALCULATED THE ONE-, TWO-, THREE-, AND FOUR-YEAR OBSERVED SURVIVAL PERCENTAGES USING US WEIGHTS FROM 1990-2009.

  • Oncology
  • Opioid
  • Celgene Corporation
  • Gilead Sciences, Inc.
  • Roche Group

However, they are associated with a number of side effects such as weight gain and high blood pressure.

  • Oncology
  • AbbVie Inc.
  • Amryt Pharma plc
  • Celgene Corporation
  • Fibrocell Science, Inc.

FATIGUE, FEVER, AND WEIGHT LOSS ARE ALSO COMMON RA SYMPTOMS ASSOCIATED WITH ONGOING INFLAMMATION.

  • Oncology
  • Demand
  • Forecast
  • Pfizer Inc.
  • Sanofi S.A.
  • CHEMOTHERAPY DRUGS MARKET : PRODUCT OUTLOOK

A few of the side effects of undergoing chemo include: affects such cells in the following areas: Blood Hair Skin Lining of the intestinal tract Nausea and vomiting easy bruising and excessive bleeding diarrhoea dry mouth mouth sores fatigue a fever hair loss or Alopecia CHEMOTHERAPY DRUGS

  • Oncology
  • Opioid
  • World
  • Bristol-Myers Squibb Company
  • Celgene Corporation

Persistent cough, shortness of breath, frequent chest infections, coughing up blood, pain or discomfort in the chest and weight loss.

  • Oncology
  • Opioid
  • Market Size
  • AstraZeneca PLC
  • Merck & Co., Inc.

AEs of Grade III or higher in the TS-## and UFT/ LV groups were diarrhea, loss of appetite, elevated total bilirubin value, elevated AST, and elevated ALT (Taiho Pharma, press release, January ##, 2013).

  • Oncology
  • Opioid
  • Therapy
  • Market Size
  • Merck & Co., Inc.

PEOPLE SUFFERING FROM UC OFTEN EXPERIENCE LOSS OF APPETITE, FATIGUE, AND WEIGHT LOSS.

  • Oncology
  • Opioid
  • AbbVie Inc.
  • Pfizer Inc.
  • Remicade group

GISTs can be asymptomatic or present with various non-specific signs, depending on the location and size of tumor, such as loss of appetite, anemia, weight loss, fatigue, abdominal discomfort or fullness, nausea, vomiting, as well as an abdominal mass, blood in stool, and

  • Oncology
  • Incyte Corporation
  • Merck & Co., Inc.
  • Novartis AG
  • Roche Group
  • Global cancer supportive care market for CINV 2016-2021 ($ billions)
  • Cancer pain

CINV affects the quality of life of individuals, leading to metabolic disturbances, reduced physical and mental well-being, anorexia, weight loss, restricted functional ability, and non-compliance with chemotherapy treatment.

  • Cancer
  • Chemotherapy
  • Oncology
  • Opioid
  • Therapy

Common symptoms include swollen lymph nodes, itching, night sweats, fatigue, unexplained weight loss, and intermittent fever (Armitage, 2005).

  • Cancer
  • Oncology
  • Opioid
  • United States
  • Forecast

Fatigue, fever, and weight loss are also common RA symptoms. ##. ##. ## RHEUMATOID ARTHRITIS Stage one, or early-stage RA, involves initial inflammation in the joint capsule and swelling of synovial tissue.

  • Oncology
  • Opioid
  • AbbVie Inc.
  • Janssen Biotech, Inc.
  • Johnson & Johnson

Chapter ## provides an introduction to the report.

  • Cancer
  • Oncology
  • Specialty Hospital
  • United States
  • Demand
  • 4.1 ETIOLOGY AND PATHOPHYSIOLOGY

GlobalData epidemiologists calculated the age-standardized one-year total prevalence by multiplying the age-specific one-year total prevalence proportions from each country by the age-specific world standard population weights (Segi, 1960).

  • Opioid
  • Therapy
  • United States
  • Forecast
  • Omeros Corporation

COMMON SYMPTOMS OF CRC ARE: BLOOD IN STOOL, STOMACH PAINS, ACHES OR CRAMPS THAT DO NOT GO AWAY, WEIGHT LOSS, AND A PERSISTENT CHANGE IN BOWEL HABIT (CDC, 2016; NHS, 2015).

  • Oncology
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.

The signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, and feeling tired all the time.

  • Oncology
  • World
  • Market Size
  • Biocept, Inc.
  • Guardant Health, Inc.
  • Cancer Treatment Drugs

Possible signs and symptoms include a lump, abnormal bleeding, prolonged cough, unexplained weight loss and a change in bowel movements.

  • Oncology
  • China
  • Demand
  • Forecast
  • Market Size
  • CHAPTER IV OVARIAN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

Most women with ovarian cancer report one or more symptoms such as abdominal pain or discomfort, an abdominal mass, bloating, back pain, urinary urgency, constipation, tiredness and a range of other non-specific symptoms, as well as more specific symptoms such as pelvic pain, abnormal vagin

  • Oncology
  • China
  • ACON Biotech Co., Ltd
  • Bayer Schering Pharmaceutical Co., Ltd
  • Ltd Jiangsu Hengrui Medicine Co.

THIS IN TURN LEADS TO MALABSORPTION OF INGESTED FOOD, MALNUTRITION AND WEIGHT LOSS.

  • Oncology
  • Opioid
  • Market Size
  • Astellas Pharma Inc.
  • AstraZeneca PLC

Glucose levels and intraocular pressure are measured today, but just one measurement at a time in the doctor' s office.

  • Oncology
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • CANCER VACCINES MARKET, GLOBAL, SYMPTOMS OF KEY INDICATION CANCERS, 2016

However, the effect of weight loss on the general risk of cancer among obese patients has been poorly characterized, as only a small proportion of obese people are able to achieve sustained weight loss (Wolin et al., 2010).

  • Oncology
  • Opioid
  • Market Size
  • Juno Therapeutics Inc.
  • Merck & Co., Inc.

Most women with ovarian cancer report one or more symptoms such as abdominal pain or discomfort, an abdominal mass, bloating, back pain, urinary urgency, constipation, tiredness and a range of other non-specific symptoms, as well as more specific symptoms such as pelvic pain, abnormal vagin

  • Oncology
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Roche Group
  • Disease overview

CINV affects the quality of life of individuals, leading to metabolic disturbances, reduced physical and mental well-being, anorexia, weight loss, restricted functional ability, and non-compliance with chemotherapy treatment.

  • Oncology
  • Opioid
  • Eisai Co., Ltd.
  • GlaxoSmithKline plc
  • Helsinn Group
  • 3.1.8 AVASTIN (BEVACIZUMAB) - ROCHE/GENENTECH

Metastatic breast cancer has a variety of non-specific symptoms, such as unexplained weight loss, fever, chills, and bone pain.

  • Oncology
  • Opioid
  • AstraZeneca PLC
  • Novartis AG
  • Roche Group
  • SAFETY OF XALKORI IN PREVIOUSLY TREATED, METASTATIC NSCLC

THESE SYMPTOMS CAN INCLUDE HEMOPTYSIS (COUGHING UP BLOOD), DYSPNEA (SHORTNESS OF BREATH), MALAISE, WEIGHT LOSS, AND HOARSENESS.

  • Oncology
  • Opioid
  • Eli Lilly & Co.
  • Novartis AG
  • Pfizer Inc.

A number of AEs occurred more frequently in the roflumilast treatment groups than in placebo groups, including diarrhea (##-##%), weight loss (##- ##%), and nausea (##%) (Bayer, 2012).

  • Oncology
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc
  • Novartis AG

Some patients experience nausea or a feeling of fullness due to an enlarged liver and spleen; this can result in unintentional weight loss.

  • Oncology
  • Opioid
  • China
  • Supply
  • Zhejiang Expressway Co., Ltd.

PROFILES OF HEALTH, AUSTRALIA, 2011-## - HEIGHT AND WEIGHT.

  • Oncology
  • Australia
  • Merck & Co., Inc.
  • Novartis AG
  • Roche Group

THE WEIGHT OF EACH ATTRIBUTE REFLECTS ITS RELATIVE IMPORTANCE IN HNSCC.

  • Oncology
  • Opioid
  • Japan
  • United States
  • Merck & Co., Inc.

Less common symptoms include weight loss, rheumatoid nodules and, rarely, inflammation in other organs and tissues, including the eyes, heart and lungs. ##. ## Symptoms Rheumatoid nodules are firm, fleshy, subcutaneous lumps that can appear on the hands, feet and elbows.

  • Oncology
  • Opioid
  • AbbVie Inc.
  • Galapagos NV
  • Pfizer Inc.